SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
China Medicine Corporation (CHME) 当前追踪市盈率 (P/E) 为 0.2. 追踪盈利收益率为 555.56%.
本页证实的标准:
- VALUE (100/100, 通过) — 市盈率低于市场平均水平 (0.2); 盈利收益率超过债券收益率 (555.56%).
- 追踪盈利收益率 555.56% — 超过典型债券收益率（约4.3%），使股票相对固定收益更具吸引力。
SharesGrow 综合评分： 65/100 其中 3/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
✓
健康
100/100
Debt-to-Equity & liquidity
→ Health
估值概览 — CHME
估值倍数
P/E (TTM)0.2
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$0.11
每股账面价值$0.00
每股营收$4.20
每股自由现金流$0.00
收益率与内在价值
盈利收益率555.56%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2004 |
$0.39 |
$10.4M |
$2.94M |
28.3% |
| 2005 |
$-0.01 |
$0.00 |
$-32.5K |
- |
| 2006 |
$0.63 |
$23.99M |
$4.79M |
20% |
| 2007 |
$0.50 |
$42.11M |
$6.88M |
16.3% |
| 2008 |
$0.60 |
$53.65M |
$9.13M |
17% |
| 2009 |
$0.11 |
$64.75M |
$1.72M |
2.7% |
